Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: The EBMT experience
Ugo De Giorgi*, T. Demirer, H. Wandt, C. Taverna, W. Siegert, M. Bornhauser, T. Kozak, G. Papiani, M. Ballardini, G. Rosti, M. Marangolo, G. Ehninger, M. Suttorp, Carl Gustav Carus, D. Lutz, A. P. Schwarer, A. Thyss, H. Ludwig, G. Baumgartner, B. LioureA. Gratwohl, B. Hertenstein, K. Welte, R. Blasczyk, Y. Beguin, B. Metzner, K. Orchard, J. Garcia-Conde, C. Devalck, A. D. Moicean, R. Marcus, S. McCann, S. A. Schey, G. Juliusson, S. Lenhoff, K. Kolbe, E. Morra, J. F. Rossi, I. Yaniv, V. Koza, M. Freund, M. Bjorkholm, H. Greinix, W. Hinterberger
Research output: Contribution to journal › Article › peer-review
75Scopus
citations
Fingerprint
Dive into the research topics of 'Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: The EBMT experience'. Together they form a unique fingerprint.